Filing Details
- Accession Number:
- 0001144204-14-060795
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-14 07:54:25
- Reporting Period:
- 2014-10-09
- Filing Date:
- 2014-10-14
- Accepted Time:
- 2014-10-14 06:54:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1434868 | Esperion Therapeutics Inc. | ESPR | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1419701 | L.p. Partners Venture Longitude | C/O Longitude Capital Partners, Llc 800 El Camino Real, Suite 220 Menlo Park CA 94025 | No | No | Yes | No | |
| 1430719 | Longitude Capital Associates, L.p. | C/O Longitude Capital Partners, Llc 800 El Camino Real, Suite 220 Menlo Park CA 94025 | No | No | Yes | No | |
| 1430720 | Longitude Capital Partners, Llc | 800 El Camino Real, Suite 220 Menlo Park CA 94025 | No | No | Yes | No | |
| 1431159 | Juliet Bakker Tammenoms | C/O Longitude Capital Partners, Llc 800 El Camino Real, Suite 220 Menlo Park CA 94025 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-10-09 | 924 | $30.00 | 1,883,769 | No | 4 | S | Indirect | By LVP |
| Common Stock | Disposition | 2014-10-09 | 19 | $30.00 | 37,757 | No | 4 | S | Indirect | By LCA |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By LVP |
| No | 4 | S | Indirect | By LCA |
Footnotes
- This report is filed jointly by Longitude Capital Partners, LLC ("LCP"), Longitude Venture Partners, L.P. ("LVP"), Longitude Capital Associates, L.P. ("LCA") and Juliet Tammenoms Bakker ("Bakker"), all of whom share beneficial ownership of more than 10% of the capital stock of the Issuer. LCP, as the general partner of each of LVP and LCA, has the power to vote and dispose of securities held by each of them and may be deemed to have beneficial ownership of the shares held by LVP and LCA. Patrick G. Enright, who serves on the Board of Directors of the Issuer and files separate Section 16 reports relating to the Issuer, and Bakker are each managing members of LCP. Each of LCP and Bakker disclaims beneficial ownership of the securities of the Issuer held by LVP and LCA except to the extent of their respective pecuniary interest therein.
Billionaire Hedge Funds
